John H. Albright has been appointed head of regulatory affairs and compliance for Celsis Rapid Detection, Celsis International. In his new role, Mr. Albright will be the liaison to key regulatory bodies and industry associations influencing the pharmaceutical, home care, cosmetics and personal care and beverage markets served by Celsis. He will also serve as a regulatory adviser and consultant to companies either using or evaluating Celsis technology to streamline their manufacturing and testing processes.
Prior to joining Celsis, Mr. Albright spent 13 years in both the Diagnostic and Pharmaceutical Operations divisions of Abbott Laboratories. He served in a variety of project management positions including quality systems validation manager, product technical support and R&D. During his tenure, he drove the successful development, launch and production of global immunoassay products.
“John Albright adds an important customer focus to our regulatory services,” said Jay LeCoque, chief executive officer of Celsis. “His experience in quality assurance testing and validations, coupled with his track record for global regulatory approvals, makes him uniquely qualified to counsel companies looking at rapid methods to streamline their manufacturing process without sacrificing quality or control.”